New board appointment at Unigene
This article was originally published in Scrip
Unigene Laboratories (US) has appointed Zvi Eiref to its board of directors as an independent director. Mr Eiref has more than 30 years' financial management and operating experience, primarily in the consumer packaged goods business, including a 20-year tenure as the chief financial officer of Church & Dwight Co.
You may also be interested in...
Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.
Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC
The latest drug development news and highlights from the Pink Sheet’s FDA Performance Tracker.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.